Home / News & Updates / Platform News
MiaoLingBio and Singapore Biotech Company Explore Strategic Partnership for Global Research Markets
MiaoLingBio and Singapore Biotech Company Explore Strategic Partnership for Global Research Markets
MiaoLingBio welcomes a Singapore biotech company to discuss international plasmid distribution, digital platforms, global market development, and long-term strategic collaboration.
Publish:2026-07-31 Views:261 View More →
MiaoLingPlasmid Launches In-House Automated Equipment for Standardized Plasmid Fulfillment
MiaoLingPlasmid Launches In-House Automated Equipment for Standardized Plasmid Fulfillment
MiaoLingPlasmid launches an in-house automated system integrating tube capping, labeling, laser coding, and tray loading to improve plasmid fulfillment speed, consistency, and quality.
Publish:2026-07-17 Views:267 View More →
MiaoLingPlasmid Corporate Video | 10+ Years of Plasmid Expertise Empowering Life Science Research
MiaoLingPlasmid Corporate Video | 10+ Years of Plasmid Expertise Empowering Life Science Research
Discover MiaoLingPlasmid’s 10+ years of expertise in plasmid vectors, standardized production, technical services, and reliable delivery for life science and biomedical research.
Publish:2026-07-08 Views:207 View More →
Custom E. coli Expression Plasmids: Efficient Support for High-Purity Recombinant Protein Production
Custom E. coli Expression Plasmids: Efficient Support for High-Purity Recombinant Protein Production
Explore custom E. coli expression plasmid services covering vector selection, codon optimization, tag design, sequence verification, plasmid preparation, and protein expression support.
Publish:2026-06-17 Views:410 View More →
High-Purity, High-Copy Plasmids: A Foundation for Modern Molecular Biology Research
High-Purity, High-Copy Plasmids: A Foundation for Modern Molecular Biology Research
Learn how high-purity, high-copy plasmids support molecular biology research, including cell transfection, viral packaging, protein expression, and CRISPR gene editing.
Publish:2026-05-13 Views:286 View More →
Enabling the Ideal Research Environment: P43339 pLV3-CMV-OVAL(Ck)-CopGFP-Puro Supports the Study of VCP-Mediated Regulation of CD8+ T Cells in HCC
Enabling the Ideal Research Environment: P43339 pLV3-CMV-OVAL(Ck)-CopGFP-Puro Supports the Study of VCP-Mediated Regulation of CD8+ T Cells in HCC
Discover how P43339 pLV3-CMV-OVAL(Ck)-CopGFP-Puro supported the generation of Hepa 1–6-OVA cells for investigating VCP-mediated regulation of CD8+ T cell function in the HCC tumor microenvironment.
Publish:2026-05-13 Views:291 View More →
收藏本站×

请按 Ctrl + D 键将本页加入收藏夹。

Mac 用户请按 ⌘ + D 键。